BG28847A3 - Method of obtaining of hydantion derivatives - Google Patents

Method of obtaining of hydantion derivatives

Info

Publication number
BG28847A3
BG28847A3 BG037604A BG3760477A BG28847A3 BG 28847 A3 BG28847 A3 BG 28847A3 BG 037604 A BG037604 A BG 037604A BG 3760477 A BG3760477 A BG 3760477A BG 28847 A3 BG28847 A3 BG 28847A3
Authority
BG
Bulgaria
Prior art keywords
obtaining
derivatives
hydantion
proven
formulated
Prior art date
Application number
BG037604A
Other languages
Bulgarian (bg)
English (en)
Inventor
Reinhard Sarges
Original Assignee
Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/767,803 external-priority patent/US4117230A/en
Application filed by Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware filed Critical Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Publication of BG28847A3 publication Critical patent/BG28847A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BG037604A 1976-10-18 1977-10-18 Method of obtaining of hydantion derivatives BG28847A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73306276A 1976-10-18 1976-10-18
US05/767,803 US4117230A (en) 1976-10-18 1977-02-11 Hydantoin derivatives as therapeutic agents

Publications (1)

Publication Number Publication Date
BG28847A3 true BG28847A3 (en) 1980-07-15

Family

ID=27112515

Family Applications (1)

Application Number Title Priority Date Filing Date
BG037604A BG28847A3 (en) 1976-10-18 1977-10-18 Method of obtaining of hydantion derivatives

Country Status (29)

Country Link
JP (3) JPS5353653A (zh)
AR (1) AR220901A1 (zh)
AT (1) AT356136B (zh)
AU (1) AU504978B2 (zh)
BG (1) BG28847A3 (zh)
CA (1) CA1088945A (zh)
CH (1) CH625511A5 (zh)
DD (1) DD131931A5 (zh)
DE (4) DE2759927C2 (zh)
DK (1) DK150302C (zh)
ES (1) ES463267A1 (zh)
FI (1) FI62307C (zh)
FR (1) FR2367754A1 (zh)
GB (1) GB1566171A (zh)
GR (1) GR70201B (zh)
HK (1) HK53881A (zh)
IE (1) IE45805B1 (zh)
IL (1) IL53094A0 (zh)
KE (1) KE3167A (zh)
LU (1) LU78330A1 (zh)
MX (1) MX4899E (zh)
MY (1) MY8200157A (zh)
NL (1) NL167434C (zh)
NO (1) NO148453C (zh)
NZ (1) NZ185358A (zh)
PH (1) PH15639A (zh)
PT (1) PT67164B (zh)
SE (1) SE437024B (zh)
YU (1) YU40821B (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives
US4147797A (en) * 1978-08-11 1979-04-03 Pfizer Inc. Spiro-furanohydantoin derivatives
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4283409A (en) * 1979-10-29 1981-08-11 Pfizer Inc. Imidazolone derivatives
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
EP0065392B1 (en) * 1981-05-13 1985-02-13 Imperial Chemical Industries Plc Pharmaceutical compositions containing spiro succinimide derivatives
JPS58213717A (ja) * 1982-01-20 1983-12-12 Eisai Co Ltd ヒダントイン誘導体を含有する治療用薬剤
JPS59500617A (ja) * 1982-04-15 1984-04-12 アルコン・ラボラトリ−ズ・インコ−ポレ−テッド ヒダントイン治療剤
ZA839023B (en) * 1982-12-06 1985-07-31 Pfizer Spiro-3-hetero-azolones for treatment of diabetic complications
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
HU198051B (en) * 1984-10-30 1989-07-28 Pfizer Process for producing spiro square brackets open imidazolidine-4,5'(6h)-quinoline square brackets closed-2,5-dione derivatives
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―3―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
JPS6357588A (ja) * 1986-08-28 1988-03-12 Sanwa Kagaku Kenkyusho Co Ltd ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤
HU204832B (en) * 1987-09-04 1992-02-28 Pfizer Process for producing spiro-(imidazolidine-4,4'-pyrano/2,3-b/pyridine) derivatives and pharmaceutical compositions comprising same
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists
WO2003088915A2 (en) * 2002-04-18 2003-10-30 University Of Virginia Patent Foundation Novel sodium channel blockers
FR2955107B1 (fr) 2010-01-08 2012-03-02 Servier Lab Nouveaux derives thiochromanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
DE2449030A1 (de) * 1974-10-11 1976-05-20 Schering Ag Neue pyridin-derivate
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents

Also Published As

Publication number Publication date
NL167434C (nl) 1981-12-16
HK53881A (en) 1981-11-13
JPS5495575A (en) 1979-07-28
NL7711358A (nl) 1978-04-20
FI62307B (fi) 1982-08-31
JPS607997B2 (ja) 1985-02-28
JPS5940388B2 (ja) 1984-09-29
JPS5495570A (en) 1979-07-28
IE45805L (en) 1978-04-18
LU78330A1 (fr) 1979-06-01
MY8200157A (en) 1982-12-31
FI62307C (fi) 1982-12-10
MX4899E (es) 1982-12-14
ATA745977A (de) 1979-09-15
DK461377A (da) 1978-04-19
NO148453B (no) 1983-07-04
CH625511A5 (en) 1981-09-30
PT67164B (en) 1979-03-20
DK150302B (da) 1987-02-02
AU2943177A (en) 1979-04-12
CA1088945A (en) 1980-11-04
DE2746244C2 (de) 1983-05-19
AR220901A1 (es) 1980-12-15
DE2759543C2 (de) 1987-04-09
JPS5353653A (en) 1978-05-16
FR2367754A1 (fr) 1978-05-12
ES463267A1 (es) 1978-07-16
IL53094A0 (en) 1977-12-30
SE437024B (sv) 1985-02-04
PH15639A (en) 1983-03-11
FR2367754B1 (zh) 1982-07-09
AU504978B2 (en) 1979-11-01
DD131931A5 (de) 1978-08-09
DE2759927C2 (de) 1986-12-04
GB1566171A (en) 1980-04-30
DE2746244A1 (de) 1978-04-20
IE45805B1 (en) 1982-12-01
NO148453C (no) 1983-10-12
NL167434B (nl) 1981-07-16
YU40821B (en) 1986-06-30
SE7711053L (sv) 1978-04-19
GR70201B (zh) 1982-08-31
DK150302C (da) 1987-09-28
KE3167A (en) 1981-11-06
FI773060A (fi) 1978-04-19
PT67164A (en) 1977-11-01
YU244277A (en) 1982-08-31
AT356136B (de) 1980-04-10
NZ185358A (en) 1979-06-08
DE2759542C2 (zh) 1988-07-07
JPS5534132B2 (zh) 1980-09-04
NO773548L (no) 1978-04-19

Similar Documents

Publication Publication Date Title
BG28708A3 (en) Method of obtaining of imidazole derivatives
BG28847A3 (en) Method of obtaining of hydantion derivatives
BG31225A3 (en) Method for obtaining of acilanilid derivatives
BG31497A3 (en) Method for obtaining of 4- amino- 5- alkyl- sulphonyl ortoanizamid
BG31499A3 (en) Method for obtaining of 1- vinyl- triazol derivatives
BG35189A3 (en) Method for preparing derivatives of 6- beta- hydroxyalkylpenicillanic acid
BG32115A4 (en) Method for obtaining of midantion
BG33294A3 (en) Method for obtaining the derivatives of 4- dezacetyl- vincaledcoblactine c- 3- carboxyhydrazid
BG38333A3 (en) Method for preparing substituted phenylcarboxyoximes
BG37995A3 (en) Method for preparing derivatives of 2- cyanbenzimidazol
BG38334A3 (en) Method for preparing pyrolidinic derivatives
BG35328A3 (en) Method for preparing imidodisulphamidic derivatives
BG28261A3 (en) Method of obtaining of imidazol derivatives
BG32268A3 (en) Method for obtaining of imidazol derivatives
BG36348A3 (en) Method for preparing thienopyridinon derivatives
BG28072A4 (en) Method of obtaining of 1-substitvated canamyzine derivatives
BG31498A3 (en) Method for obtaining of pyridiliminomethyl benzene derivatives
BG31073A3 (en) Method for obtaining of 1, 5- substituated- 2- pyrolidine
BG38638A3 (en) Method for preparing arylcyclobutyl- aminoderivatives
BG35897A3 (en) Method for preparing 5- (dihydroxy- phenoxy)- 1h- tetrazoles
BG38338A3 (en) Method for preparing 6 alpha- methylhydrocortisonic derivatives
BG32116A3 (en) Method for obtaining of 4- amino- oleandomicine derivatives
BG35032A3 (en) Method for preparing 1, 1, 2- triphenylpropene derivatives
BG31947A3 (en) Method for obtaining of acetidine derivatives
BG34460A3 (en) Method of obtaining derivatives of 7 beta-amino- thiazolylacetamido-3-cephem-4-carbonic acid